2BB score and signals
Candel Therapeutics, Inc.’s current 2BB score is 43 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 59 | Moderate |
| Momentum | 53 | Stable |
| Financial strength | 12 | Very Weak |
| Quality | 75 | Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Needham, Massachusetts, United States |
| Founded | 2003 |
| Employees | 55 |
| 52-week range | $4.35 – $14.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-10 | — | -0.3563 | — | $0.00 |
| 2026-11-05 | — | -0.3665 | — | $0.00 |
| 2026-08-19 | — | -0.2414 | — | $0.00 |
| 2026-05-14 | -0.14 | -0.3232 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish